Accelerate Gene Therapy: PurProX® AAV Purification Solutions
From bench to clinic: flexible, high-performance solutions for every stage.
Learn MoreFrom bench to clinic: flexible, high-performance solutions for every stage.
Learn More· 50 nm superparamagnetic: rapid response and stable control.
· Versatile formats: column-based (enhanced) and column-free (easy) options.
· Broad compatibility: designed for mainstream cell separation equipment.
Highly specific anti-payload antibodies for precise PK/PD analysis of MMAE, DXd, SN38, and more.
Learn MoreProviding comprehensive solutions for gene and cell therapy
Offering complete AAV workflow support from purification to titer detection, efficiently empowering gene therapy R&D.
High-quality flow cytometry antibodies, VHH detection antibodies, and cell sorting solutions to precisely support cell analysis.
Highly specific anti-Payload antibodies and advanced antibody engineering platforms to accelerate biologics development.
An AI-driven innovative technology platform accelerating the drug development process
Integrating AI-assisted protein design and antibody development technologies to create ligands with high affinity and specificity, providing core technical support for purification resins.
In-house development, evaluation, and production system for affinity media (microspheres, nanobeads, etc.), ensuring comprehensive optimization of performance, production capacity, and continuous supply.
Covers AAV virus production, purification, and process development, AAV capsid evolution, with extensive experience in large-scale production across multiple serotypes.
A platform for multi-immune cell separation, purification, amplification, functional characterization, and closed-loop process validation, ensuring process stability.
Exceptional quality, professional services, empowering every research endeavor
Strict compliance with ISO 9001 & ISO 13485 standards, establishing a digital quality traceability system to ensure product excellence.
30+ interdisciplinary experts with an average of 10+ years of industry experience, deeply understanding GCT and antibody development needs.
AI-driven product design platform, combined with a million-level biological big database, accelerating product iteration and performance enhancement.
Innovative Bioproducts, Empowering Gene & Cell Therapy
Founded in 2018 by a team of interdisciplinary scientists with extensive experience in drug R&D, CMC process development, computational biology, and materials chemistry, GeneMedi / YaoNuo Biotech is dedicated to providing efficient purification and quality control solutions for gene and cell therapy (GCT) drug development.